Back to today’s briefing

Story perspectives

New Weight Loss Drug Ecnoglutide Shows 15.1% Average Loss

7/24/2025

34 4

Summary

Story summary

Ecnoglutide, a groundbreaking weight loss drug from Sciwind Biosciences in China, is making waves in clinical trials with an impressive average weight loss of 15.1%—and it keeps going! With fewer side effects than semaglutide, researchers are hopeful, yet they emphasize that lifestyle changes remain crucial for lasting results. More research is on the horizon to explore its long-term effects.

1 of 1

Story summary

Ecnoglutide, a groundbreaking weight loss drug from Sciwind Biosciences in China, is making waves in clinical trials with an impressive average weight loss of 15.1%—and it keeps going! With fewer side effects than semaglutide, researchers are hopeful, yet they emphasize that lifestyle changes remain crucial for lasting results. More research is on the horizon to explore its long-term effects.